{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:09:17Z","timestamp":1791288557743,"version":"4.3.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Korea Ministry of Education","doi-asserted-by":"publisher","award":["RS-2022-NR075245"],"award-info":[{"award-number":["RS-2022-NR075245"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijantimicag.2026.107734","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:06:18Z","timestamp":1770307578000},"page":"107734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["CRISPR\/Cas9-engineered Salmonella phage displaying antimicrobial peptide LL37 for enhanced antibacterial activity"],"prefix":"10.1016","volume":"67","author":[{"given":"Su Jin","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Chang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Guen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107734_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8899596","article-title":"Prevention and control of human Salmonella enterica infections: an implication in food safety","volume":"2023","author":"Mkangara","year":"2023","journal-title":"Int J Food Sci"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0002","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/vaccines12070758","article-title":"The economic burden of non-typhoidal Salmonella and invasive non-typhoidal Salmonella infection: a systematic literature review","volume":"12","author":"Kim","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0003","series-title":"Molecular medical microbiology","first-page":"1207","article-title":"Interactions of nontyphoidal Salmonella with host cells","author":"Santana","year":"2024"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2655801","article-title":"Mechanisms for the invasion and dissemination of Salmonella","volume":"2022","author":"Li","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijantimicag.2018.09.004","article-title":"Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review","volume":"53","author":"Kakasis","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0006","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/microorganisms11092311","article-title":"The biotechnological application of bacteriophages: what to do and where to go in the middle of the post-antibiotic era","volume":"11","author":"Jo","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI187996","article-title":"Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches","volume":"135","author":"Kim","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0008","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4014\/jmb.1710.10049","article-title":"Recent trends in Salmonella outbreaks and emerging technology for biocontrol of Salmonella using phages in foods: a review","volume":"27","author":"Oh","year":"2017","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0009","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/MMBR.00069-15","article-title":"Genetically engineered phages: a review of advances over the last decade","volume":"80","author":"Pires","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12275-024-00107-2","article-title":"Use of Cas9 targeting and Red recombination for designer phage engineering","volume":"62","author":"Choi","year":"2024","journal-title":"J Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0011","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1473-3099(24)00424-9","article-title":"Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial","volume":"24","author":"Kim","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.00019-20","article-title":"In vivo targeting of clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials","volume":"11","author":"Selle","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0013","article-title":"Genetic engineering of a temperate phage-based delivery system for CRISPR\/Cas9 antimicrobials against Staphylococcus aureus","volume":"7","author":"Park","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40259-021-00480-z","article-title":"Engineered bacteriophage therapeutics: rationale, challenges and future","volume":"35","author":"\u0141obocka","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0015","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fmicb.2019.01043","article-title":"The effect of previous life cycle phase on the growth kinetics, morphology, and antibiotic resistance of Salmonella Typhimurium DT104 in brain heart infusion and ground chicken extract","volume":"10","author":"Hawkins","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antibiotics14010002","article-title":"Standardization of the agar plate method for bacteriophage production","volume":"14","author":"Jo","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0017","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00284-024-03713-w","article-title":"Genomic insights into novel Erwinia bacteriophages: unveiling their Henunavirus membership and host infection strategies","volume":"81","author":"Jo","year":"2024","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105997","article-title":"Synergistic phage\u2013surfactant combination clears IgE-promoted Staphylococcus aureus aggregation in vitro and enhances the effect in vivo","volume":"56","author":"Kim","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0019","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3390\/antibiotics11111566","article-title":"Phage cocktail in combination with kasugamycin as a potential treatment for fire blight caused by Erwinia amylovora","volume":"11","author":"Kim","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0020","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/AEM.70.6.3417-3424.2004","article-title":"Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157: H7","volume":"70","author":"O'flynn","year":"2004","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135351","article-title":"Characterization of novel factors involved in swimming and swarming motility in Salmonella enterica serovar Typhimurium","volume":"10","author":"Deditius","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0022","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.rvsc.2013.06.001","article-title":"Isolation and characterization of a Myoviridae bacteriophage against Staphylococcus aureus isolated from dairy cows with mastitis","volume":"95","author":"Han","year":"2013","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0023","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00441-018-02984-7","article-title":"Human cathelicidin improves colonic epithelial defenses against Salmonella typhimurium by modulating bacterial invasion, TLR4 and pro-inflammatory cytokines","volume":"376","author":"Marin","year":"2019","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13567-018-0597-8","article-title":"Inhibition of Salmonella Typhimurium adhesion, invasion, and intracellular survival via treatment with methyl gallate alone and in combination with marbofloxacin","volume":"49","author":"Birhanu","year":"2018","journal-title":"Vet Res"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127052","article-title":"Efficacy and safety of phage therapy against Salmonella enterica serovars Typhimurium and Enteritidis estimated by using a battery of in vitro tests and the Galleria mellonella animal model","volume":"261","author":"Kosznik-Kwa\u015bnicka","year":"2022","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0026","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tim.2018.10.008","article-title":"Phage therapy: going temperate?","volume":"27","author":"Monteiro","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106951","article-title":"Sequential treatment effects on phage\u2013antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii","volume":"62","author":"Mukhopadhyay","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2021.11.005","article-title":"European regulatory aspects of phage therapy: magistral phage preparations","volume":"52","author":"Verbeken","year":"2022","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0029","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12275-019-8686-6","article-title":"Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018","volume":"57","author":"Lemon","year":"2019","journal-title":"J Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/frabi.2024.1515874","article-title":"Analysis of engineered T7 bacteriophages containing genetic sequences encoding antimicrobial peptides","volume":"3","author":"Ludwig","year":"2025","journal-title":"Front Antibiot"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0031","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bpj.2009.09.060","article-title":"Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37","volume":"98","author":"Thennarasu","year":"2010","journal-title":"Biophys J"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0032","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/jb.89.2.537-538.1965","article-title":"Streptomycin induction of premature lysis of bacteriophage-infected mycobacteria","volume":"89","author":"Tokunaga","year":"1965","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000819","article-title":"Rational design of balanced dual-targeting antibiotics with limited resistance","volume":"18","author":"Nyerges","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijantimicag.2012.07.020","article-title":"The importance of antimicrobial peptides and their potential for therapeutic use in ophthalmology","volume":"41","author":"Silva","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0035","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00253-019-09629-x","article-title":"Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy","volume":"103","author":"Azam","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0036","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41564-020-00830-7","article-title":"Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials","volume":"6","author":"Gordillo Altamirano","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0037","doi-asserted-by":"crossref","first-page":"R1120","DOI":"10.1016\/j.cub.2020.07.036","article-title":"Trading-off and trading-up in the world of bacteria\u2013phage evolution","volume":"30","author":"Burmeister","year":"2020","journal-title":"Curr Biol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001010","article-title":"Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37","volume":"6","author":"Kai-Larsen","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0039","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2958.2010.07219.x","article-title":"Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4-like bacteriophages","volume":"77","author":"Sathaliyawala","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fbioe.2020.00571","article-title":"Multi-enzyme assembly on T4 phage scaffold","volume":"8","author":"Liu","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0041","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jviromet.2006.09.017","article-title":"Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: a powerful immunological approach","volume":"139","author":"Wu","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2025.110487","article-title":"Design of multi-epitope chimeric phage nanocarrier vaccines for porcine deltacoronavirus","volume":"304","author":"Zhao","year":"2025","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0043","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tim.2014.01.007","article-title":"To acquire or resist: the complex biological effects of CRISPR\u2013Cas systems","volume":"22","author":"Bondy-Denomy","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0044","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2026.107734_bib0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41587-023-01759-y","article-title":"Engineered phage with antibacterial CRISPR\u2013Cas selectively reduce E. coli burden in mice","volume":"42","author":"Gencay","year":"2024","journal-title":"Nat Biotechnol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:13:04Z","timestamp":1777583584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0924857926000233"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107734","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/Cas9-engineered Salmonella phage displaying antimicrobial peptide LL37 for enhanced antibacterial activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107734"}}